TXMD - Therapeutics MD GAAP EPS of -$5.69 misses by $1.69 revenue of $19.34M beats by $1.39M May, 16 2022 04:23 PM TherapeuticsMD Inc. Therapeutics MD press release (NASDAQ:TXMD): Q1 GAAP EPS of -$5.69 misses by $1.69. Revenue of $19.34M (-2.7% Y/Y) beats by $1.39M. For further details see: Therapeutics MD GAAP EPS of -$5.69 misses by $1.69, revenue of $19.34M beats by $1.39M